LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
about
Purification of proteins associated with specific genomic LociRecognition of RNA duplexes by chemically modified triplex-forming oligonucleotidesMiR-210--micromanager of the hypoxia pathwayStability and mismatch discrimination of locked nucleic acid-DNA duplexesThe influence of locked nucleic acid residues on the thermodynamic properties of 2'-O-methyl RNA/RNA heteroduplexesPotential Role of JAK-STAT Signaling Pathway in the Neurogenic-to-Gliogenic Shift in Down Syndrome BrainMicroRNAs as pharmacological targets in diabetesFrom evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transportBioinformatic tools for microRNA dissectionMethodological challenges in utilizing miRNAs as circulating biomarkersNon-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand ActivityNMR structure of a kissing complex formed between the TAR RNA element of HIV-1 and a LNA-modified aptamerEnhancement of the Seed-Target Recognition Step in RNA Silencing by a PIWI/MID Domain ProteinThe crystal structure of an 'All Locked' nucleic acid duplexNanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.Effect of an N-substituent in sulfonamide-bridged nucleic acid (SuNA) on hybridization ability and duplex structuremicroRNA Therapeutics in Cancer - An Emerging ConceptModeling of miRNA and drug action in the EGFR signaling pathwaySynthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicingMicrornas in prostate cancer: an overview.RNA Whole-Mount In situ Hybridisation Proximity Ligation Assay (rISH-PLA), an Assay for Detecting RNA-Protein Complexes in Intact Cells.Oxetane locked thymidine in the Dickerson-Drew dodecamer causes local base pairing distortions -- an NMR structure and hydration study.Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targetsInhibiting gene expression with locked nucleic acids (LNAs) that target chromosomal DNA.Optimization of cDNA microarrays procedures using criteria that do not rely on external standardsA rapid synthetic route to conformationally restricted [5,5]-bicyclic nucleoside-amino acid conjugates.Locked nucleic acid pentamers as universal PCR primers for genomic DNA amplificationGlioma angiogenesis: Towards novel RNA therapeutics.Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice.A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repairCrystallization and preliminary X-ray diffraction data of an LNA 7-mer duplex derived from a ricin aptamer.From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded Oligonucleotides.MicroRNAs and micromanaging the skeleton in disease, development and evolutionPharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates.Determinants of initiation codon selection during translation in mammalian cellsMicroRNAs: critical mediators of differentiation, development and disease.The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.miRNAs in human cancer.Advanced methods for the analysis of chromatin-associated proteins.Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro.
P2860
Q24315634-DC852E88-3527-4BD3-9309-382CAD392168Q24599584-22FA4170-4625-436F-ACFD-53646F2B368BQ24628401-61A295D1-E0E8-4E4A-9983-7F958711700CQ24634415-064C3588-F587-4013-9F86-BDD997783763Q24812616-CDBDD575-778F-4258-B328-E78A30F7B2D3Q26765647-71357F85-69D8-440D-91A1-BEB27B0F930AQ26824024-234BAE1D-8A8D-4360-9633-0D8321D14D56Q26997647-4C5830EF-E6F3-4AE4-B39A-4C71BA289D05Q27004412-F750B3F8-5B06-492E-9007-5E3DE501BCCCQ27027950-E523EFA8-9941-4B3E-B496-A7DF671111DBQ27345210-BE4F06B9-2EC1-4AF0-A7BE-ECC1E75882AFQ27647789-99B07662-10FE-4C71-B4A6-CC54E078ED2AQ27653626-71FE3305-809D-423C-9F61-31C74F74ABA4Q27662137-158A007C-DFEA-4620-9B08-B692DE584922Q27692125-47152955-5497-4CD3-974B-25AE3B5A10FAQ27710131-C45E1D8B-DC1B-4605-8C97-5AB31104D85CQ28068855-B12358B7-F0FC-4310-865B-585F899D43E6Q28478852-4B37334F-3BA4-449D-99AD-D6BF9A702130Q28830393-4D074378-99FF-4077-8454-D883DA6AFA86Q30234658-F4691691-3366-4D0F-AD31-E60632C7ECBFQ30360950-2F314191-6CF9-464B-B35E-A38A8944F0F7Q31010768-6A2ABC9A-A938-45A9-BB49-BF7FEE76C46AQ33245746-9969615C-E746-428E-A400-066B5C11FE8FQ33286173-93169E54-CDED-46BA-8E83-58A3810F7174Q33303246-CCB1A43C-8DED-41E9-80AC-206BC4BDAE0BQ33359427-533024BD-B93E-4497-9510-1623DCC72D15Q33383821-C269C6CE-D123-4624-A8F3-B4AF2EEF7B68Q33414996-4CC13DDF-D54B-4948-BF78-39541C8F7D8CQ33427174-015CC857-2791-4169-B3BA-B945C3B213E9Q33432320-2FDDE3D0-13A8-4EE3-AC35-35FCF7C1A570Q33499182-A62FDEF6-E3E6-4D87-93FF-F883625EED20Q33632091-BDBDC441-4F61-4779-9E4F-96D6D3AE7D0BQ33689739-53EB64A0-0FE0-44F6-89EA-3F8B076FFBE4Q33750824-368CF6C9-2401-4391-BE01-9FE5F328CA99Q33760873-F3D5661A-DCAE-47C9-B985-71D9C331BAA2Q33786949-3EEDA9C8-3151-4FBD-94D7-428DF599917EQ33798887-5EBD5B00-C4BD-488A-ADB9-B948F70878E1Q33827750-C62F5EF9-7019-45D8-A6A4-D7151DB69C5AQ33840345-F1B9B08B-F770-4455-B14C-F923A8411534Q33843195-CF88EB0F-5354-4F5B-B5A0-583D13A33638
P2860
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
@ast
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
@en
LNA
@nl
type
label
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
@ast
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
@en
LNA
@nl
prefLabel
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
@ast
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
@en
LNA
@nl
P356
P1433
P1476
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA
@en
P2093
Jesper Wengel
P304
13233-13241
P356
10.1021/BI0485732
P407
P50
P577
2004-10-01T00:00:00Z